Let`s talk about compounds: 492-27-3

《Alterations of kynurenine pathway in alcohol use disorder and abstinence: a link with gut microbiota, peripheral inflammation and psychological symptoms》 provides a strategy for the preparation of materials with excellent comprehensive properties, which is conducive to broaden the application field of this compound(4-Hydroxyquinoline-2-carboxylic Acid)SDS of cas: 492-27-3.

The reaction of an aromatic heterocycle with a proton is called a protonation. One of articles about this theory is 《Alterations of kynurenine pathway in alcohol use disorder and abstinence: a link with gut microbiota, peripheral inflammation and psychological symptoms》. Authors are Leclercq, Sophie; Schwarz, Markus; Delzenne, Nathalie M.; Starkel, Peter; de Timary, Philippe.The article about the compound:4-Hydroxyquinoline-2-carboxylic Acidcas:492-27-3,SMILESS:O=C(C1=NC2=CC=CC=C2C(O)=C1)O).SDS of cas: 492-27-3. Through the article, more information about this compound (cas:492-27-3) is conveyed.

Abstract: The gut-brain communication is mostly driven by the immune, metabolic and neural pathways which remained poorly explored in patients with alc. use disorder (AUD). The metabolites arising from the tryptophan-kynurenine pathway have gained considerable attention since they are at the interface between intestinal bacteria, host immune response and brain functions. This study described the circulating levels of kynurenine metabolites in AUD patients, at the onset (T1) and end (T2) of a 3-wk detoxification program, and tested correlations between those metabolites and inflammatory markers, the gut microbiota and the psychol. symptoms. Increased concentration of the neurotoxic metabolite quinolinic acid (QUIN) and decreased levels of the neuroprotector metabolite kynurenic acid (KYNA) which both modulate glutamatergic neurotransmission were observed in AUD patients, particularly at T2. The inflammatory marker hsCRP was associated with several metabolic ratios of the kynurenine pathway. Tryptophan, KYNA and QUIN were correlated with depression, alc. craving and reaction time, resp. Anal. of gut microbiota revealed that bacteria known as short-chain fatty acid producers, as well as bacterial metabolites including butyrate and medium-chain fatty acids were associated with some metabolites of the tryptophan-kynurenine pathway. Targeting the glutamatergic neurotransmission through the modulation of the kynurenine pathway, by manipulating the gut microbiota, might represent an interesting alternative for modulating alc.-related behavior.

《Alterations of kynurenine pathway in alcohol use disorder and abstinence: a link with gut microbiota, peripheral inflammation and psychological symptoms》 provides a strategy for the preparation of materials with excellent comprehensive properties, which is conducive to broaden the application field of this compound(4-Hydroxyquinoline-2-carboxylic Acid)SDS of cas: 492-27-3.

Reference:
Copper catalysis in organic synthesis – NCBI,
Special Issue “Fundamentals and Applications of Copper-Based Catalysts”

 

Fun Route: New Discovery of 492-27-3

《Tryptophan catabolites in bipolar disorder: a meta-analysis》 provides a strategy for the preparation of materials with excellent comprehensive properties, which is conducive to broaden the application field of this compound(4-Hydroxyquinoline-2-carboxylic Acid)Category: copper-catalyst.

Hebbrecht, Kaat; Skorobogatov, Katrien; Giltay, Erik J.; Coppens, Violette; De Picker, Livia; Morrens, Manuel published the article 《Tryptophan catabolites in bipolar disorder: a meta-analysis》. Keywords: meta analysis tryptophan bipolar disorder; bipolar disorder; depression; immune; inflammation; kynurenine; tryptophan.They researched the compound: 4-Hydroxyquinoline-2-carboxylic Acid( cas:492-27-3 ).Category: copper-catalyst. Aromatic heterocyclic compounds can be divided into two categories: single heterocyclic and fused heterocyclic. In addition, there is a lot of other information about this compound (cas:492-27-3) here.

Tryptophan catabolites (TRYCATs) are implicated in the pathophysiol. of mood disorders by mediating immune-inflammation and neurodegenerative processes. Author performed a meta-anal. of TRYCAT levels in bipolar disorder (BD) patients compared to healthy controls. A systematic literature search in seven electronic databases (PubMed, Embase, Web of Science, Cochrane, Emcare, PsycINFO, Academic Search Premier) was conducted on TRYCAT levels in cerebrospinal fluid or peripheral blood according to the PRISMA statement. A min. of three studies per TRYCAT was required for inclusion. Standardized mean differences (SMD) were computed using random effect models. Subgroup analyses were performed for BD patients in a different mood state (depressed, manic). The methodol. quality of the studies was rated using the modified Newcastle-Ottawa Quality assessment Scale. Twenty-one eligible studies were identified. Peripheral levels of tryptophan (SMD = -0.44; p < 0.001), kynurenine (SMD = - 0.3; p = 0.001) and kynurenic acid (SMD = -.45; p = < 0.001) were lower in BD patients vs. healthy controls. In the only three eligible studies investigating TRP in cerebrospinal fluid, tryptophan was not significantly different between BD and healthy controls. Themethodol. quality of the studies was moderate. Subgroup analyses revealed no significant difference in TRP and KYN values between manic and depressed BD patients, but these results were based on a limited number of studies. The TRYCAT pathway appears to be downregulated in BD patients. There is a need for more and high-quality studies of peripheral and central TRYCAT levels, preferably using longitudinal designs. 《Tryptophan catabolites in bipolar disorder: a meta-analysis》 provides a strategy for the preparation of materials with excellent comprehensive properties, which is conducive to broaden the application field of this compound(4-Hydroxyquinoline-2-carboxylic Acid)Category: copper-catalyst.

Reference:
Copper catalysis in organic synthesis – NCBI,
Special Issue “Fundamentals and Applications of Copper-Based Catalysts”

 

Final Thoughts on Chemistry for 492-27-3

《Redressing the interactions between stem cells and immune system in tissue regeneration》 provides a strategy for the preparation of materials with excellent comprehensive properties, which is conducive to broaden the application field of this compound(4-Hydroxyquinoline-2-carboxylic Acid)SDS of cas: 492-27-3.

Fang, Jiankai; Feng, Chao; Chen, Wangwang; Hou, Pengbo; Liu, Zhanhong; Zuo, Muqiu; Han, Yuyi; Xu, Chenchang; Melino, Gerry; Verkhratsky, Alexei; Wang, Ying; Shao, Changshun; Shi, Yufang published an article about the compound: 4-Hydroxyquinoline-2-carboxylic Acid( cas:492-27-3,SMILESS:O=C(C1=NC2=CC=CC=C2C(O)=C1)O ).SDS of cas: 492-27-3. Aromatic heterocyclic compounds can be classified according to the number of heteroatoms or the size of the ring. The authors also want to convey more information about this compound (cas:492-27-3) through the article.

A review. Skeletal muscle has an extraordinary regenerative capacity reflecting the rapid activation and effective differentiation of muscle stem cells (MuSCs). In the course of muscle regeneration, MuSCs are reprogrammed by immune cells. In turn, MuSCs confer immune cells anti-inflammatory properties to resolve inflammation and facilitate tissue repair. Indeed, MuSCs can exert therapeutic effects on various degenerative and inflammatory disorders based on their immunoregulatory ability, including effects primed by interferon-γ (IFN-γ) and tumor necrosis factor-α (TNF-α). At the mol. level, the tryptophan metabolites, kynurenine or kynurenic acid, produced by indoleamine 2,3-dioxygenase (IDO), augment the expression of TNF-stimulated gene 6 (TSG6) through the activation of the aryl hydrocarbon receptor (AHR). In addition, insulin growth factor 2 (IGF2) produced by MuSCs can endow maturing macrophages oxidative phosphorylation (OXPHOS)-dependent anti-inflammatory functions. Herein, we summarize the current understanding of the immunomodulatory characteristics of MuSCs and the issues related to their potential applications in pathol. conditions, including COVID-19.

《Redressing the interactions between stem cells and immune system in tissue regeneration》 provides a strategy for the preparation of materials with excellent comprehensive properties, which is conducive to broaden the application field of this compound(4-Hydroxyquinoline-2-carboxylic Acid)SDS of cas: 492-27-3.

Reference:
Copper catalysis in organic synthesis – NCBI,
Special Issue “Fundamentals and Applications of Copper-Based Catalysts”

 

Awesome and Easy Science Experiments about 492-27-3

Different reactions of this compound(4-Hydroxyquinoline-2-carboxylic Acid)Category: copper-catalyst require different conditions, so the reaction conditions are very important.

Category: copper-catalyst. The fused heterocycle is formed by combining a benzene ring with a single heterocycle, or two or more single heterocycles. Compound: 4-Hydroxyquinoline-2-carboxylic Acid, is researched, Molecular C10H7NO3, CAS is 492-27-3, about Dysregulation of kynurenine pathway and potential dynamic changes of kynurenine in schizophrenia: A systematic review and meta-analysis. Author is Cao, Bing; Chen, Yan; Ren, Zhongyu; Pan, Zihang; McIntyre, Roger S.; Wang, Dongfang.

Meta-Anal. of. The kynurenine (KYN) pathway is postulated to play various roles in immune system dysregulation of schizophrenia (SCZ). We conducted a meta-anal. to explore the association between six key metabolites of KYN pathway (i.e., tryptophan (TRP), KYN, quinolinic acid (QUIN), and kynurenic acid (KYNA)) and SCZ. Priori Bonferroni adjustments were conducted for multiple comparisons. In total, 42 studies that examined the relationship between the metabolites in KYN pathway mentioned above and SCZ in 4217 participants and nine studies that examined alterations of these metabolites after antipsychotic treatments were included. The results demonstrate that (1) subjects with prescribed medication had significantly higher KYN levels when compared to controls; (2) higher KYN levels in cerebrospinal fluid (CSF), lower plasma KYN levels and higher CSF KYNA levels were associated with SCZ; (3) the KYN levels were higher in subjects with SCZ after antipsychotic treatments when compared with baseline. The evidence provides valuable insight of the potential underlying involvement of the KYN pathway in the pathogenesis of SCZ.

Different reactions of this compound(4-Hydroxyquinoline-2-carboxylic Acid)Category: copper-catalyst require different conditions, so the reaction conditions are very important.

Reference:
Copper catalysis in organic synthesis – NCBI,
Special Issue “Fundamentals and Applications of Copper-Based Catalysts”

 

Chemistry Milestones Of 492-27-3

Different reactions of this compound(4-Hydroxyquinoline-2-carboxylic Acid)HPLC of Formula: 492-27-3 require different conditions, so the reaction conditions are very important.

The reaction of an aromatic heterocycle with a proton is called a protonation. One of articles about this theory is 《Kynurenic acid may underlie sex-specific immune responses to COVID-19》. Authors are Cai, Yuping; Kim, Daniel J.; Takahashi, Takehiro; Broadhurst, David I.; Yan, Hong; Ma, Shuangge; Rattray, Nicholas J. W.; Casanovas-Massana, Arnau; Israelow, Benjamin; Klein, Jon; Lucas, Carolina; Mao, Tianyang; Moore, Adam J.; Muenker, M. Catherine; Oh, Ji Eun; Silva, Julio; Wong, Patrick; Ko, Albert I.; Khan, Sajid A.; Iwasaki, Akiko; Johnson, Caroline H..The article about the compound:4-Hydroxyquinoline-2-carboxylic Acidcas:492-27-3,SMILESS:O=C(C1=NC2=CC=CC=C2C(O)=C1)O).HPLC of Formula: 492-27-3. Through the article, more information about this compound (cas:492-27-3) is conveyed.

Coronavirus disease 2019 (COVID-19) has poorer clin. outcomes in males than in females, and immune responses underlie these sex-related differences. Because immune responses are, in part, regulated by metabolites, we examined the serum metabolomes of COVID-19 patients. In male patients, kynurenic acid (KA) and a high KAtokynurenine (K) ratio (KA:K) pos. correlated with age and with inflammatory cytokines and chemokines and neg. correlated with T cell responses. Males that clin. deteriorated had a higher KA:K than those that stabilized. KA inhibits glutamate release, and glutamate abundance was lower in patients that clin. deteriorated and correlated with immune responses. Anal. of data from the Genotype-Tissue Expression (GTEx) project revealed that the expression of the gene encoding the enzyme that produces KA, kynurenine aminotransferase, correlated with cytokine abundance and activation of immune responses in older males. This study reveals that KA has a sex-specific link to immune responses and clin. outcomes in COVID-19, suggesting a pos. feedback between metabolites and immune responses in males.

Different reactions of this compound(4-Hydroxyquinoline-2-carboxylic Acid)HPLC of Formula: 492-27-3 require different conditions, so the reaction conditions are very important.

Reference:
Copper catalysis in organic synthesis – NCBI,
Special Issue “Fundamentals and Applications of Copper-Based Catalysts”

 

Discovery of 492-27-3

Different reactions of this compound(4-Hydroxyquinoline-2-carboxylic Acid)Quality Control of 4-Hydroxyquinoline-2-carboxylic Acid require different conditions, so the reaction conditions are very important.

Pyun, Do Hyeon; Kim, Tae Jin; Kim, Myeong Jun; Hong, Soon Auck; Abd El-Aty, A. M.; Jeong, Ji Hoon; Jung, Tae Woo published an article about the compound: 4-Hydroxyquinoline-2-carboxylic Acid( cas:492-27-3,SMILESS:O=C(C1=NC2=CC=CC=C2C(O)=C1)O ).Quality Control of 4-Hydroxyquinoline-2-carboxylic Acid. Aromatic heterocyclic compounds can be classified according to the number of heteroatoms or the size of the ring. The authors also want to convey more information about this compound (cas:492-27-3) through the article.

Endoplasmic reticulum (ER) stress plays a causative role in the development of nonalcoholic fatty liver disease (NAFLD). Kynurenic acid (KA) is a tryptophan metabolite that has been shown to exert anti-inflammatory effects in macrophages and endothelial cells. However, the role of KA in ER stress-associated development of NAFLD has not been fully explored. In the current study, we observed decreased KA levels in the serum of obese subjects. Treated hepatocytes with KA attenuated palmitate-induced lipid accumulation and downregulated lipogenesis-associated genes as well as ER stress markers in a dose-dependent manner. Furthermore, KA augmented AMP-activated protein kinase (AMPK) phosphorylation, oxygen-regulated protein 150 (ORP150) expression, and autophagy markers. The small interfering RNA-mediated suppression of AMPK and ORP150, or 3-methyladenine also abrogated the effects of KA on ER stress and lipid accumulation in hepatocytes. In accordance with in vitro observations, KA administration to mice fed a high-fat diet ameliorated hepatic lipid accumulation and decreased the expression of lipogenic genes as well as ER stress. Moreover, KA treatment increased hepatic AMPK phosphorylation, ORP150 expression, and autophagy related markers in mouse livers. Knockdown of AMPK using in vivo transfection mitigated the effects of KA on hepatic steatosis and ER stress as well as autophagy and ORP150 expression. These results suggest that KA ameliorates hepatic steatosis via the AMPK/autophagy- and AMPK/ORP150-mediated suppression of ER stress. In sum, KA might be used as a promising therapeutic agent for treatment of NAFLD.

Different reactions of this compound(4-Hydroxyquinoline-2-carboxylic Acid)Quality Control of 4-Hydroxyquinoline-2-carboxylic Acid require different conditions, so the reaction conditions are very important.

Reference:
Copper catalysis in organic synthesis – NCBI,
Special Issue “Fundamentals and Applications of Copper-Based Catalysts”

 

Simple exploration of 492-27-3

Different reactions of this compound(4-Hydroxyquinoline-2-carboxylic Acid)Application In Synthesis of 4-Hydroxyquinoline-2-carboxylic Acid require different conditions, so the reaction conditions are very important.

Pommer, Stefan; Akamine, Yumiko; Schiffmann, Serge N.; de Kerchove d’Exaerde, Alban; Wickens, Jeffery R. published the article 《The effect of serotonin receptor 5-HT1B on lateral inhibition between spiny projection neurons in the mouse striatum》. Keywords: spiny projection neuron serotonin receptor 5 HT1B lateral inhibition; GABA; MSN; SPN; lateral inhibition; serotonin; synapse.They researched the compound: 4-Hydroxyquinoline-2-carboxylic Acid( cas:492-27-3 ).Application In Synthesis of 4-Hydroxyquinoline-2-carboxylic Acid. Aromatic heterocyclic compounds can be divided into two categories: single heterocyclic and fused heterocyclic. In addition, there is a lot of other information about this compound (cas:492-27-3) here.

The principal neurons of the striatum, the spiny projection neurons (SPNs), make inhibitory synaptic connections with each other via collaterals of their main axon, forming a local lateral inhibition network. Serotonin, acting via the 5-HT1B receptor, modulates neurotransmitter release from SPN terminals in striatal output nuclei, but the role of 5-HT1B receptors in lateral inhibition among SPNs in the striatum is unknown. Here, we report the effects of 5-HT1B receptor activation on lateral inhibition in the mouse striatum. Whole-cell recordings were made from SPNs in acute brain slices of either sex, while optogenetically activating presynaptic SPNs or fast-spiking interneurons (FSIs). Activation of 5-HT1B receptors significantly reduced the amplitude of IPSCs evoked by optical stimulation of both direct and indirect pathway SPNs. This reduction was blocked by application of a 5-HT1B receptor antagonist. Activation of 5-HT1B receptors did not reduce the amplitude of IPSCs evoked from FSIs. These results suggest a new role for serotonin as a modulator of lateral inhibition among striatal SPNs. The 5-HT1B receptor may, therefore, be a suitable target for future behavioral experiments investigating the currently unknown role of lateral inhibition in the function of the striatum.

Different reactions of this compound(4-Hydroxyquinoline-2-carboxylic Acid)Application In Synthesis of 4-Hydroxyquinoline-2-carboxylic Acid require different conditions, so the reaction conditions are very important.

Reference:
Copper catalysis in organic synthesis – NCBI,
Special Issue “Fundamentals and Applications of Copper-Based Catalysts”

 

Awesome and Easy Science Experiments about 492-27-3

Different reactions of this compound(4-Hydroxyquinoline-2-carboxylic Acid)Category: copper-catalyst require different conditions, so the reaction conditions are very important.

Category: copper-catalyst. The fused heterocycle is formed by combining a benzene ring with a single heterocycle, or two or more single heterocycles. Compound: 4-Hydroxyquinoline-2-carboxylic Acid, is researched, Molecular C10H7NO3, CAS is 492-27-3, about Dysregulation of kynurenine pathway and potential dynamic changes of kynurenine in schizophrenia: A systematic review and meta-analysis. Author is Cao, Bing; Chen, Yan; Ren, Zhongyu; Pan, Zihang; McIntyre, Roger S.; Wang, Dongfang.

Meta-Anal. of. The kynurenine (KYN) pathway is postulated to play various roles in immune system dysregulation of schizophrenia (SCZ). We conducted a meta-anal. to explore the association between six key metabolites of KYN pathway (i.e., tryptophan (TRP), KYN, quinolinic acid (QUIN), and kynurenic acid (KYNA)) and SCZ. Priori Bonferroni adjustments were conducted for multiple comparisons. In total, 42 studies that examined the relationship between the metabolites in KYN pathway mentioned above and SCZ in 4217 participants and nine studies that examined alterations of these metabolites after antipsychotic treatments were included. The results demonstrate that (1) subjects with prescribed medication had significantly higher KYN levels when compared to controls; (2) higher KYN levels in cerebrospinal fluid (CSF), lower plasma KYN levels and higher CSF KYNA levels were associated with SCZ; (3) the KYN levels were higher in subjects with SCZ after antipsychotic treatments when compared with baseline. The evidence provides valuable insight of the potential underlying involvement of the KYN pathway in the pathogenesis of SCZ.

Different reactions of this compound(4-Hydroxyquinoline-2-carboxylic Acid)Category: copper-catalyst require different conditions, so the reaction conditions are very important.

Reference:
Copper catalysis in organic synthesis – NCBI,
Special Issue “Fundamentals and Applications of Copper-Based Catalysts”

 

Chemistry Milestones Of 492-27-3

Different reactions of this compound(4-Hydroxyquinoline-2-carboxylic Acid)HPLC of Formula: 492-27-3 require different conditions, so the reaction conditions are very important.

The reaction of an aromatic heterocycle with a proton is called a protonation. One of articles about this theory is 《Kynurenic acid may underlie sex-specific immune responses to COVID-19》. Authors are Cai, Yuping; Kim, Daniel J.; Takahashi, Takehiro; Broadhurst, David I.; Yan, Hong; Ma, Shuangge; Rattray, Nicholas J. W.; Casanovas-Massana, Arnau; Israelow, Benjamin; Klein, Jon; Lucas, Carolina; Mao, Tianyang; Moore, Adam J.; Muenker, M. Catherine; Oh, Ji Eun; Silva, Julio; Wong, Patrick; Ko, Albert I.; Khan, Sajid A.; Iwasaki, Akiko; Johnson, Caroline H..The article about the compound:4-Hydroxyquinoline-2-carboxylic Acidcas:492-27-3,SMILESS:O=C(C1=NC2=CC=CC=C2C(O)=C1)O).HPLC of Formula: 492-27-3. Through the article, more information about this compound (cas:492-27-3) is conveyed.

Coronavirus disease 2019 (COVID-19) has poorer clin. outcomes in males than in females, and immune responses underlie these sex-related differences. Because immune responses are, in part, regulated by metabolites, we examined the serum metabolomes of COVID-19 patients. In male patients, kynurenic acid (KA) and a high KAtokynurenine (K) ratio (KA:K) pos. correlated with age and with inflammatory cytokines and chemokines and neg. correlated with T cell responses. Males that clin. deteriorated had a higher KA:K than those that stabilized. KA inhibits glutamate release, and glutamate abundance was lower in patients that clin. deteriorated and correlated with immune responses. Anal. of data from the Genotype-Tissue Expression (GTEx) project revealed that the expression of the gene encoding the enzyme that produces KA, kynurenine aminotransferase, correlated with cytokine abundance and activation of immune responses in older males. This study reveals that KA has a sex-specific link to immune responses and clin. outcomes in COVID-19, suggesting a pos. feedback between metabolites and immune responses in males.

Different reactions of this compound(4-Hydroxyquinoline-2-carboxylic Acid)HPLC of Formula: 492-27-3 require different conditions, so the reaction conditions are very important.

Reference:
Copper catalysis in organic synthesis – NCBI,
Special Issue “Fundamentals and Applications of Copper-Based Catalysts”

 

Discovery of 492-27-3

Different reactions of this compound(4-Hydroxyquinoline-2-carboxylic Acid)Quality Control of 4-Hydroxyquinoline-2-carboxylic Acid require different conditions, so the reaction conditions are very important.

Pyun, Do Hyeon; Kim, Tae Jin; Kim, Myeong Jun; Hong, Soon Auck; Abd El-Aty, A. M.; Jeong, Ji Hoon; Jung, Tae Woo published an article about the compound: 4-Hydroxyquinoline-2-carboxylic Acid( cas:492-27-3,SMILESS:O=C(C1=NC2=CC=CC=C2C(O)=C1)O ).Quality Control of 4-Hydroxyquinoline-2-carboxylic Acid. Aromatic heterocyclic compounds can be classified according to the number of heteroatoms or the size of the ring. The authors also want to convey more information about this compound (cas:492-27-3) through the article.

Endoplasmic reticulum (ER) stress plays a causative role in the development of nonalcoholic fatty liver disease (NAFLD). Kynurenic acid (KA) is a tryptophan metabolite that has been shown to exert anti-inflammatory effects in macrophages and endothelial cells. However, the role of KA in ER stress-associated development of NAFLD has not been fully explored. In the current study, we observed decreased KA levels in the serum of obese subjects. Treated hepatocytes with KA attenuated palmitate-induced lipid accumulation and downregulated lipogenesis-associated genes as well as ER stress markers in a dose-dependent manner. Furthermore, KA augmented AMP-activated protein kinase (AMPK) phosphorylation, oxygen-regulated protein 150 (ORP150) expression, and autophagy markers. The small interfering RNA-mediated suppression of AMPK and ORP150, or 3-methyladenine also abrogated the effects of KA on ER stress and lipid accumulation in hepatocytes. In accordance with in vitro observations, KA administration to mice fed a high-fat diet ameliorated hepatic lipid accumulation and decreased the expression of lipogenic genes as well as ER stress. Moreover, KA treatment increased hepatic AMPK phosphorylation, ORP150 expression, and autophagy related markers in mouse livers. Knockdown of AMPK using in vivo transfection mitigated the effects of KA on hepatic steatosis and ER stress as well as autophagy and ORP150 expression. These results suggest that KA ameliorates hepatic steatosis via the AMPK/autophagy- and AMPK/ORP150-mediated suppression of ER stress. In sum, KA might be used as a promising therapeutic agent for treatment of NAFLD.

Different reactions of this compound(4-Hydroxyquinoline-2-carboxylic Acid)Quality Control of 4-Hydroxyquinoline-2-carboxylic Acid require different conditions, so the reaction conditions are very important.

Reference:
Copper catalysis in organic synthesis – NCBI,
Special Issue “Fundamentals and Applications of Copper-Based Catalysts”